Summary:
Have you or a loved one been diagnosed with Schizophrenia?
Segal Trials is conducting an inpatient clinical research study to evaluate the safety and efficacy of an investigational medication for patients with Schizophrenia.
Study details:
Between the ages of 18-65
Diagnosed with Schizophrenia
Experiencing an Acute Exacerbation or relapse of psychotic symptoms
Qualified Participants May Receive:
Participants who qualify may receive: